EXECUTION COPY
EXHIBIT 99.1
================================================================================
STOCK PURCHASE AGREEMENT
BY AND AMONG
SALTON, INC.
AND
HARBINGER CAPITAL PARTNERS MASTER FUND I, LTD.
--------------------
DATED AS OF DECEMBER 28, 2006
---------------------
================================================================================
TABLE OF CONTENTS
I. DEFINITIONS...........................................................1
1.1. Definitions ...................................................1
1.2. Interpretation.................................................4
II. STOCK PURCHASE........................................................4
2.1. Issued Shares..................................................4
2.2. Securities Act Exemption and Compliance; Registration Rights...5
III. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.........................5
3.1. Due Organization, Good Standing and Corporate Power............6
3.2. Authorization and Validity of Agreement........................6
3.3. Consents and Approvals; No Violations..........................6
3.4. Capitalization of the Company..................................7
3.5. Absence of Certain Events......................................8
3.6. Company SEC Reports; Financial Statements......................8
3.7. Broker's or Finder's Fee.......................................8
3.8. State Takeover Laws............................................9
IV. REPRESENTATIONS AND WARRANTIES OF THE INVESTOR........................9
4.1. Due Organization, Good Standing and Corporate Power............9
4.2. Authorization and Validity of Agreement........................9
4.3. Consents and Approvals; No Violations..........................9
4.4. Broker's or Finder's Fee......................................10
4.5. Investor Representations......................................10
V. COVENANTS............................................................10
5.1. Efforts to Close..............................................10
5.2. Fees and Expenses.............................................10
VI. CONDITIONS TO THE CLOSINGS...........................................10
6.1. Conditions to the Closing.....................................10
6.2. Conditions to the Obligations of the Investor.................11
6.3. Conditions to the Obligations of the Company..................11
VII. TERMINATION AND ABANDONMENT..........................................12
7.1. Termination ..................................................12
VIII. MISCELLANEOUS .......................................................12
8.1. Nonsurvival of Representations, Warranties and Covenants......12
8.2. Amendment and Modification....................................12
8.3. Waiver of Compliance..........................................12
8.4. Notices ......................................................12
8.5. Third Party Beneficiaries.....................................13
8.6. Successors and Assigns........................................13
8.7. Severability..................................................13
8.8. Governing Law.................................................14
-i-
8.9. Submission to Jurisdiction; Waivers...........................14
8.10. Specific Performance..........................................14
8.11. Counterparts .................................................14
8.12. Entire Agreement..............................................15
8.13. Waiver of Jury Trial..........................................15
-ii-
EXHIBITS
Exhibit A Form of Registration Rights Agreement
-iii-
STOCK PURCHASE AGREEMENT
STOCK PURCHASE AGREEMENT (this "Agreement"), is dated as of December 28,
2006, by and among Salton, Inc., a Delaware corporation (the "Company"), and
Harbinger Capital Partners Master Fund I, Ltd. (the "Investor").
RECITALS
A. The Investor has agreed to purchase, and the Company has agreed to
issue, Seven Hundred and One Thousand Six Hundred (701,600) shares of common
stock, $0.01 par value, of the Company (the "Company Common Stock").
B. The Company's board of directors (acting upon the unanimous
recommendation of the Special Committee) has approved this Agreement and the
transactions contemplated hereby.
C. Concurrently with the execution of this Agreement, and as a condition to
the willingness of the Investor to enter into this Agreement, the Company and
the Investor will enter into a registration rights agreement in the form
attached hereto as Exhibit A (the "Registration Rights Agreement"), pursuant to
which the Investor will be entitled to registration rights with respect to the
Issued Shares (as hereinafter defined) on terms and subject to the conditions
set forth therein.
Accordingly, the parties agree as follows:
I. DEFINITIONS
1.1. Definitions. (a) In addition to the terms defined elsewhere herein,
as used in this Agreement, the following terms have the meanings specified below
when used in this Agreement with initial capital letters:
"Action" means any controversy, claim, action, litigation, arbitration,
mediation or any other proceeding by or before any Governmental Entity,
arbitrator, mediator or other Person acting in a dispute resolution capacity, or
any investigation, subpoena or demand preliminary to any of the foregoing.
"Affiliate" means, with respect to a Person, another Person that directly,
or indirectly through one or more intermediaries, controls, or is controlled by,
or is under common control with, such Person. For purposes of this Agreement,
(i) the Company and its Subsidiaries shall not be considered Affiliates of the
Investor or any of its Affiliates (other than the Company and its Subsidiaries)
and (ii) the Investor and its Affiliates shall not be considered Affiliates of
the Company or any of its Subsidiaries.
"Authorization" means any legally required consent or Permit of or from, or
declaration or filing with, any Governmental Entity, including any legally
required filing with any Governmental Entity and the subsequent expiration of
any legally required waiting period under any Antitrust Laws.
-1-
"Company Material Adverse Effect" means a material adverse effect on (i)
the business, financial condition or results of operations of the Company and
its Subsidiaries taken as a whole or (ii) the ability of the Company to perform
its obligations under this Agreement on a timely basis or to consummate the
Transactions on a timely basis; provided, however, that in no event shall any of
the following be deemed to constitute a Company Material Adverse Effect: any
event, circumstance, change or effect resulting from or relating to (i) a change
in general political, economic or financial market conditions, (ii) changes
affecting the industries generally in which the Company or its Subsidiaries
conduct business, (iii) seasonal fluctuations in the business of the Company and
its Subsidiaries, (iv) any acts of terrorism or war or (v) compliance with the
terms of, or the taking of any action required by, this Agreement; except in the
case of each of clauses (i), (ii), (iii) and (iv) to the extent such event,
circumstance, change or effect has had a disproportionate effect on the Company
and its Subsidiaries as compared to other persons in the industry in which the
Company and its Subsidiaries conduct their business.
"Confidentiality Agreement" means the confidentiality agreement entered
into by and between Harbinger Capital Partners Master Fund I, Ltd. and the
Company, dated as of October 25, 2006 and amended November 3, 2006, as the same
may be amended from time to time in accordance with its terms.
"Contract" means any legally binding instrument or legal obligation of any
kind, whether written or oral.
"control" (including the terms "controlled by" and "under common control
with") means the possession, directly or indirectly, of the power to direct or
cause the direction of the management and policies of a Person, whether through
the ownership of voting securities, as a trustee or executor, by Contract or
credit arrangement or otherwise.
"Encumbrance" means any lien, security interest, pledge, mortgage, deed of
trust, charge, option or other encumbrance attaching to title to any tangible or
intangible property or right.
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
"GAAP" means United States generally accepted accounting principles as in
effect from time to time, consistently applied.
"Governmental Entity" means any arbitrator, court, judicial, legislative,
administrative or regulatory agency, commission, department, board, bureau, body
or other governmental authority or instrumentality or any Person exercising
executive, legislative, judicial, regulatory or administrative functions of or
pertaining to government, whether foreign, federal, state or local.
"Investor Material Adverse Effect" means a material adverse effect on the
ability of the Investor to perform its obligations under this Agreement on a
timely basis or to consummate the Transactions on a timely basis.
-2-
"Knowledge" (and any variation thereof) means, in the case of the Company,
the actual knowledge after due inquiry of the individuals listed on Section
1.1(a) of the Company Disclosure Schedule as of the date of the applicable
representation or warranty.
"Law" means any statute, law, ordinance, rule or regulation of any
Governmental Entity.
"NYSE" means the New York Stock Exchange.
"Order" means any order, judgment, ruling, decree, writ, permit, license or
other requirement of any Governmental Entity.
"Permit" means any permit, approval, license, authorization, certificate,
right, exemption or Order from any Governmental Entity.
"Person" means any individual or legal entity, including any partnership,
joint venture, corporation, trust, unincorporated organization, limited
liability company or Governmental Entity.
"SEC" means the Securities and Exchange Commission.
"Securities Act" means the Securities Act of 1933, as amended.
"Special Committee" means a committee of the Company's board of directors,
the members of which are not affiliated with the Company and are not members of
the Company's management, formed for the reasons set forth in the resolution
establishing such committee.
"Subsidiary" of any Person means any Person whose financial condition is
required to be consolidated with the financial condition of the first Person in
the preparation of the first Person's financial statements under GAAP.
"Transactions" means the transactions contemplated by this Agreement.
(b) The following terms have the meanings specified in the indicated
Sections:
TERM SECTION
---- -------
Agreement Preamble
Closing 2.1(b)
Closing Date 2.1(b)
Company Preamble
Company Common Stock Recitals
Company Disclosure Schedule III
Company Equity Interests 3.4(a)
Company Financial Statements 3.6(b)
Company Options 3.4(a)
Company Preferred 3.4(a)
-3-
Company SEC Reports 3.6(a)
Company Series A Preferred 3.4(a)
Company Series B Preferred 3.4(a)
Company Series C Preferred 3.4(a)
Company Stock 3.4(a)
Company Warrants 3.4(a)
Investor Preamble
Issued Shares 2.1
Measurement Date III
Registration Rights Agreement Recitals
1.2. Interpretation. (a) When a reference is made in this Agreement to
Articles, Sections, Exhibits or Schedules, such reference will be to an Article
or Section or Exhibit or Schedule to this Agreement unless otherwise indicated.
The table of contents and headings contained in this Agreement are for reference
purposes only and will not affect in any way the meaning or interpretation of
this Agreement. Whenever the words "include," "includes" or "including" are used
in this Agreement, they will be deemed to be followed by the words "without
limitation." Unless the context otherwise requires, (i) "or" is disjunctive but
not necessarily exclusive, (ii) words in the singular include the plural and
vice versa, (iii) the use in this Agreement of a pronoun in reference to a party
hereto includes the masculine, feminine or neuter, as the context may require,
and (iv) unless otherwise defined herein, terms used herein which are defined in
GAAP have the meanings ascribed to them therein. This Agreement will not be
interpreted or construed to require any Person to take any action, or fail to
take any action, that would violate any applicable Law. The Company Disclosure
Schedule, as well as all other Schedules and all Exhibits hereto, will be deemed
part of this Agreement and included in any reference to this Agreement.
Notwithstanding anything in this Agreement to the contrary, the mere inclusion
of an item in any Schedule or Exhibit hereto as an exception to a representation
or warranty will not be deemed an admission that such item represents a material
exception or material fact, event or circumstance or that such item has had or
would, individually or in the aggregate, have a Company Material Adverse Effect.
(b) The parties have participated jointly in negotiating and drafting
this Agreement. In the event that an ambiguity or a question of intent or
interpretation arises, this Agreement will be construed as if drafted jointly by
the parties, and no presumption or burden of proof will arise favoring or
disfavoring any party by virtue of the authorship of any provision of this
Agreement.
II. STOCK PURCHASE
2.1. Issued Shares. (a) On the terms and subject to the conditions of this
Agreement, at the Closing, in consideration of the payment of $1,754,000 in cash
by the Investor to the Company, the Company shall issue to the Investor 701,600
shares of Company Common Stock (the "Issued Shares") by delivering to the
Investor a certificate or certificates representing the Issued Shares, in each
case, free and clear of all Encumbrances (other than as imposed by federal or
state securities laws).
-4-
(b) On the terms and subject to the conditions of this Agreement, the
closing of the Transactions (the "Closing") will take place at the offices of
Xxxx, Weiss, Rifkind, Xxxxxxx & Xxxxxxxx LLP, 0000 Xxxxxx xx xxx Xxxxxxxx, Xxx
Xxxx, Xxx Xxxx at 10:00 a.m., New York City time on the date hereof, as soon as
practicable following satisfaction or waiver of the conditions set forth in
Article VI hereof (other than those conditions that by their nature or pursuant
to the terms of this Agreement are to be satisfied or waived at or immediately
prior to the Closing, but subject to the satisfaction or, where permitted, the
waiver of those conditions), or at such other date, time or place as the Company
and the Investor may agree. The date on which the Closing occurs is referred to
as the "Closing Date."
2.2. Securities Act Exemption and Compliance; Registration Rights.
(a) Private Placement. The Issued Shares initially will not be
registered under the Securities Act in reliance on the exemptions from the
registration requirements of Section 5 of the Securities Act set forth in
Section 4(2) thereof and Regulation D promulgated thereunder.
(b) Legends. In addition to any legend imposed by applicable state
securities laws, the certificates representing the shares of Company Common
Stock issued pursuant to this Agreement shall bear a restrictive legend, stating
substantially as follows:
"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
"ACT"). THEY MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, OR HYPOTHECATED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO, OR, AN EXEMPTION
SUCH THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT."
(c) Registration Rights. The Investor shall be entitled to the
registration rights set forth in the Registration Rights Agreement on the terms
and subject to the conditions set forth therein.
III. REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except as disclosed in (x) the Company SEC Reports filed prior to the close
of business on December 20, 2006 (the "Measurement Date"), but excluding any
risk factor disclosure contained in any such Company SEC Reports under the
heading "Risk Factors" or "Cautionary Statement Regarding Forward Looking
Statements" or otherwise or (y) the disclosure schedule (the "Company Disclosure
Schedule") delivered by the Company to the Investor in connection with the
execution of this Agreement (which schedule sets forth, among other things,
items the disclosure of which is necessary or appropriate either in response to
an express disclosure requirement contained in a provision hereof or as an
exception to one or more representations or warranties contained in this Article
III), the Company hereby represents and warrants to the Investor as follows:
-5-
3.1. Due Organization, Good Standing and Corporate Power. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware and has all requisite corporate power and authority to
own, lease and operate its properties and to conduct its business as now being
conducted. Each of the Company's Subsidiaries is a corporation or other entity
duly organized, validly existing and in good standing or has equivalent status
under the laws of its jurisdiction of organization and has all requisite
corporate power and authority to own, lease and operate its properties and to
conduct its business as now being conducted. Each of the Company and its
Subsidiaries is duly qualified or licensed to do business and is in good
standing or has equivalent status in each jurisdiction in which the property
owned, leased or operated by it or the nature of the business conducted by it
makes such qualification necessary, except in such jurisdictions where the
failure to be so qualified or licensed and in good standing or to have
equivalent status would not, individually or in the aggregate, reasonably be
expected to have a Company Material Adverse Effect.
3.2. Authorization and Validity of Agreement. The Company has the
requisite corporate power and authority to execute and deliver this Agreement
and to perform its obligations hereunder. The execution and delivery of this
Agreement by the Company and the consummation by the Company of the
Transactions, have been duly authorized and approved by its board of directors
(acting upon the unanimous written consent of the Special Committee) and no
other corporate action on the part of the Company is necessary to authorize the
execution and delivery of this Agreement or the consummation of the
Transactions. This Agreement has been, and the Registration Rights Agreement
when executed and delivered will be, duly executed and delivered by the Company,
and each is, or will be when executed and delivered, a valid and binding
obligation of the Company enforceable against the Company in accordance with its
terms, except to the extent that its enforceability may be subject to applicable
bankruptcy, insolvency, reorganization, moratorium and similar Laws affecting
the enforcement of creditors' rights generally and by general equitable
principles.
3.3. Consents and Approvals; No Violations. Assuming (a) the applicable
requirements of the Securities Act and state securities or "blue sky" laws and
the Exchange Act are met and (b) the required notices to the NYSE related to the
Transactions are delivered, the execution and delivery of this Agreement and the
Registration Rights Agreement by the Company and the consummation by the Company
of the Transactions, do not and will not (i) violate or conflict with any
provision of its certificate of incorporation or bylaws or the comparable
governing documents of any of its Subsidiaries, (ii) violate or conflict with
any Law or Order applicable to the Company or any of its Subsidiaries or by
which any of their respective properties or assets may be bound, (iii) require
any filing with, or Permit, consent or approval of, or the giving of any notice
to, any Governmental Entity, or (iv) result in a violation or breach of,
conflict with, constitute (with or without due notice or lapse of time or both)
a default under, or give rise to any right of termination, cancellation or
acceleration of, or result in the creation of any Encumbrance upon any of the
properties or assets of the Company or any of its Subsidiaries under, or give
rise to any obligation, right of termination, cancellation, acceleration or
increase of any obligation or a loss of a material benefit under, any of the
terms, conditions or provisions of any Contract to which the Company or any of
its Subsidiaries is a party, or by which the Company or any of its Subsidiaries
may be bound, excluding in the case of clauses (iii) and (iv) above, conflicts,
violations, breaches, defaults, rights of termination, cancellations,
-6-
accelerations, increases, losses, creations and impositions of Encumbrances
which would not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect.
3.4. Capitalization of the Company.
(a) The authorized capital stock of (i) the Company consists of
40,000,000 shares of Company Common Stock, (ii) 2,000,000 shares of Preferred
Stock, 40,000 of which are designated Series A Voting Convertible Preferred
Stock, $0.01 par value per share and convertible into shares of Company Common
Stock (the "Company Series A Preferred"), 500,000 of which are designated Series
B Junior Participating Preferred Stock, $0.01 par value per share (the "Company
Series B Preferred"), 150,000 of which are designated Series C Preferred Stock,
$0.01 par value per share (the "Company Series C Preferred"), and 1,310,000 of
which are designated Preferred Stock, $0.01 par value per share (the "Company
Preferred" and together with the Company Common Stock, the Company Series A
Preferred, the Company Series B Preferred and the Company Series C Preferred,
the "Company Stock"). As of the Measurement Date, there were 14,384,390 shares
of Company Common Stock (of which 189,750 were Company Restricted Shares) issued
and outstanding, 40,000 shares of Company Series A Preferred issued and
outstanding, no shares of Company Series B Preferred issued and outstanding,
135,217 shares of Company Series C Preferred issued and outstanding, and no
shares of Company Preferred issued and outstanding. As of the Measurement Date,
no shares of Company Common Stock were reserved for issuance except for (a)
2,150,795 shares of Company Common Stock that were reserved for issuance upon
the exercise of outstanding options (the "Company Options"), (b) 719,320 shares
of Company Common Stock reserved for issuance upon the exercise of outstanding
warrants (the "Company Warrants") and (c) 3,529,412 shares of Company Common
Stock reserved for issuance upon the conversion of the Company Series A
Preferred for Company Common Stock. Between the Measurement Date and the date
hereof, the Company has not issued any shares of Company Common Stock (other
than pursuant to the exercise of Company Options outstanding as of the
Measurement Date) or awarded any Company Options. The Company Series B Preferred
are issuable in connection with the rights to purchase those shares issued under
the Rights Agreement, dated as of June 28, 2004 and as amended on June 7, 2006,
by and between the Company and UMB Bank N.A., as rights agent. All issued and
outstanding shares of Company Stock have been duly authorized and validly issued
and are fully paid and nonassessable. As of the date hereof, except as set forth
above and except for shares of Company Common Stock issuable pursuant to the
Company Options, Company Warrants and the Company Series A Preferred outstanding
as of the Measurement Date, there are no outstanding or authorized options,
warrants, rights, calls, commitments, preemptive rights, subscriptions, claims
of any character, convertible or exchangeable securities, or other Contracts,
contingent or otherwise, relating to Company Common Stock or any capital stock
or capital stock equivalent or other nominal interest in the Company or any of
its Subsidiaries which relate to the Company (collectively, "Company Equity
Interests") pursuant to which the Company or any of its Subsidiaries is or may
become obligated to issue or sell shares of its capital stock or other equity
interests or any securities convertible into, or exchangeable for, or evidencing
the right to subscribe for, any Company Equity Interests. There are no
outstanding obligations of the Company to repurchase, redeem or otherwise
acquire any outstanding securities of the Company or any Company Equity
Interests. There are no Contracts
-7-
to which the Company is a party relating to the issuance, sale, transfer,
registration or voting of any equity securities or other securities of the
Company except as listed on Section 3.4(a) of the Company Disclosure Schedule.
No bonds, debentures, notes or other indebtedness having the right to vote on
any matters on which Company Stockholders may vote are issued or outstanding as
of the date hereof.
(b) When issued in accordance with the terms of this Agreement, the
Issued Shares to be issued to the Investor pursuant to Section 2.1(a) will be
duly authorized, validly issued, fully paid and non assessable free and clear of
all Encumbrances (other than as imposed by federal or state securities laws).
3.5. Absence of Certain Events. Except as required or expressly permitted
by this Agreement or as reflected in the Company Financial Statements filed on
or prior to the Measurement Date, since July 1, 2006, there has not occurred any
event, occurrence or condition which would, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect.
3.6. Company SEC Reports; Financial Statements.
(a) Each of the Company and its Subsidiaries has timely filed with
the SEC all registration statements, prospectuses, reports, schedules, forms,
proxy statements, certifications and other documents (including exhibits and all
other information incorporated by reference therein) required to be filed by the
Company since June 28, 2003 (the "Company SEC Reports"). The Company SEC Reports
(i) were prepared and will be prepared (when filed after the date of this
Agreement) in all material respects in accordance with the requirements of the
Securities Act or the Exchange Act, as the case may be, and (ii) did not at the
time they were filed and will not, when filed after the date of this Agreement,
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements made
therein, in the light of the circumstances under which they were made, not
misleading, except to the extent corrected by a subsequent Company SEC Report
filed with the SEC prior to the date of this Agreement. No Subsidiary of the
Company is subject to the periodic reporting requirements of the Exchange Act by
Law or Contract.
(b) Each of the consolidated financial statements of the Company
(including, in each case, any notes thereto) contained in the Company SEC
Reports (the "Company Financial Statements") was prepared and will be prepared
(when filed after the date of this Agreement) in accordance with GAAP (except as
may be indicated in the notes thereto) and presented fairly and will present
fairly (when filed after the date of this Agreement) in all material respects
the consolidated financial position and consolidated results of operations of
the Company and its Subsidiaries as of the respective dates thereof and for the
respective periods indicated therein, except as otherwise noted therein and
subject, in the case of unaudited statements, to normal year end audit
adjustments in amounts that are immaterial in nature and amounts consistent with
past experience.
3.7. Broker's or Finder's Fee. No Person acting on behalf of the Company
or any of its Subsidiaries is, or will be, entitled to any investment banking,
broker's, finder's or
-8-
similar fee for which the Company, the Investor or any of their respective
Affiliates after the Closing could have any liabilities in connection with this
Agreement or any of the Transactions.
3.8. State Takeover Laws. The Company's certificate of incorporation
contains a provision expressly electing that the Company not be governed by
Section 203 of the DGCL and the Company shall not amend its certificate of
incorporation to amend or remove such election. No applicable "takeover" or
"interested stockholder" Law is applicable to this Agreement and the
Transactions.
IV. REPRESENTATIONS AND WARRANTIES OF THE INVESTOR
The Investor hereby represents and warrants to the Company as follows:
4.1. Due Organization, Good Standing and Corporate Power. The Investor is
duly organized, validly existing and in good standing under the laws of the
jurisdiction in which it is organized and has all requisite power and authority
to own, lease and operate its properties and to conduct its business as now
being conducted.
4.2. Authorization and Validity of Agreement. The Investor has the
requisite power and authority to execute and deliver this Agreement and to
perform its obligations hereunder. The execution and delivery of this Agreement
by the Investor, and the consummation by the Investor of the Transactions, have
been duly authorized and approved by all necessary action on the part of the
Investor and no other action on the part of the Investor is necessary to
authorize the execution and delivery of this Agreement or the consummation of
the Transactions. This Agreement has been and the Registration Rights Agreement
when executed and delivered will be, duly executed and delivered by the Investor
and is, or will be when executed and delivered, a valid and binding obligation
of the Investor enforceable against the Investor in accordance with its terms,
except to the extent that its enforceability may be subject to applicable
bankruptcy, insolvency, reorganization, moratorium and similar Laws affecting
the enforcement of creditors' rights generally and by general equitable
principles.
4.3. Consents and Approvals; No Violations. Assuming (a) the applicable
requirements of the Securities Act and state securities or "blue sky" laws and
the Exchange Act are met and (b) the required notices to the NYSE related to the
Transactions are delivered, the execution and delivery of this Agreement and the
Registration Rights Agreement by the Investor and the consummation by the
Investor of the Transactions, do not and will not (i) violate or conflict with
any provision of its certificate of incorporation, bylaws or other comparable
governing documents, as the case may be, (ii) violate or conflict with any Law
or Order applicable to the Investor or by which any of their respective
properties or assets may be bound, (iii) require any filing with, or Permit,
consent or approval of, or the giving of any notice to, any Governmental Entity,
or (iv) result in a violation or breach of, conflict with, constitute (with or
without due notice or lapse of time or both) a default under, or give rise to
any right of termination, cancellation or acceleration of, or result in the
creation of any Encumbrance upon any of the properties or assets of the
Investor, or give rise to any obligation, right of termination, cancellation,
acceleration or increase of any obligation or a loss of a material benefit
under, any
-9-
of the terms, conditions or provisions of any Contract to which the Investor is
a party, or by which the Investor may be bound, excluding in the case of clauses
(iii) and (iv) above, conflicts, violations, breaches, defaults, rights of
termination, cancellations, accelerations, increases, losses, creations and
impositions of Encumbrances which would not, individually or in the aggregate,
reasonably be expected to have an Investor Material Adverse Effect.
4.4. Broker's or Finder's Fee. No Person acting on behalf of the Investor
is, or will be, entitled to any investment banking, broker's, finder's or
similar fee for which the Company or any of its Affiliates after the Closing
could have any liabilities in connection with this Agreement or any of the
Transactions.
4.5. Investor Representations. The Investor acknowledges that the Company
Common Stock to be issued pursuant to this Agreement initially will not be
registered under the Securities Act in reliance on the exemptions from the
registration requirements of Section 5 of the Securities Act set forth in
Section 4(2) thereof and Regulation D promulgated thereunder. The Investor is an
"accredited investor" as such term is defined under the Securities Act, or,
alternatively, has such knowledge and experience in financial and business
matters to be capable of evaluating the merits and risks of an investment in the
Company and the Company Common Stock. The Issued Shares to be issued to the
Investor pursuant to this Agreement are being purchased for investment for the
account of the Investor and without the intent of participating directly or
indirectly in a distribution of such shares in violation of the Securities Act
or other applicable securities laws. In addition to any legend imposed by
applicable state securities laws, the certificates representing the Issued
Shares will bear the restrictive legends set forth in this Agreement.
V. COVENANTS
5.1. Efforts to Close. The Company on the one hand, and the Investor on
the other, will use its reasonable best efforts to cause all of the conditions,
as specified in Article VI, to the obligations of the other party to consummate
the Transactions to be met as soon as practicable after the date of this
Agreement.
5.2. Fees and Expenses. (a) The Investor will bear all of the fees and
expenses of the Investor and its Affiliates in connection with the Transactions
and (b) the Company will bear all of the fees and expenses of the Company and
its Affiliates in connection with the Transactions.
VI. CONDITIONS TO THE CLOSINGS
6.1. Conditions to the Closing. The respective obligations of the Company
and the Investor to effect the Transactions are subject to the satisfaction or
waiver of the following conditions:
(a) no preliminary or permanent injunction or other Order shall have
been issued that would make unlawful the consummation of the Transactions, and
consummation of the Transactions shall not be prohibited or made illegal by any
Law; and
-10-
(b) all other Authorizations of or filings with any Governmental
Entity required in connection with the consummation of the Transactions shall
have been made or obtained, except where the failure to make or obtain such
Authorizations or filings would not, individually or in the aggregate, have a
Company Material Adverse Effect or an Investor Material Adverse Effect.
6.2. Conditions to the Obligations of the Investor. The obligation of the
Investor to effect the Transactions are subject to the satisfaction of each of
the following conditions (each of which is for the exclusive benefit of the
Investor and may be waived by the Investor):
(a) all covenants of the Company under this Agreement to be performed
by the Company on or before the Closing shall have been duly performed by the
Company in all material respects;
(b) the representations and warranties of the Company in this
Agreement (which for purposes of this paragraph shall be read as though none of
them contained any materially or material adverse effect qualifications) shall
have been true and correct on the date of this Agreement and shall be true and
correct as of the Closing with the same effect as though made as of the Closing,
except where the failure of such representations and warranties to be true and
correct in all respects as of the applicable time would not, individually or in
the aggregate, have a Company Material Adverse Effect. In addition, the
representations and warranties set forth in Section 3.4 shall have been true and
correct in all material respects on the date of this Agreement and shall be true
and correct in all material respects as of the Closing with the same effect as
though made as of the Closing; and
(c) The Company shall have executed and delivered the Registration
Rights Agreement.
6.3. Conditions to the Obligations of the Company. The obligation of the
Company to effect the Transactions is subject to the satisfaction of each of the
following conditions (each of which is for the exclusive benefit of the Company
and may be waived by the Company):
(a) all covenants of the Investor under this Agreement to be
performed on or before the Closing Date shall have been duly performed by the
Investor in all material respects;
(b) the representations and warranties of the Investor in this
Agreement (which for purposes of this paragraph shall be read as though none of
them contained any materiality or material adverse effect qualifications) shall
have been true and correct on the date of this Agreement and shall be true and
correct as of the Closing with the same effect as though made as of the Closing,
except where the failure of such representations and warranties to be true and
correct in all respects as of the applicable time would not, individually or in
the aggregate, have an Investor Material Adverse Effect; and
-11-
(c) the Investor shall have executed and delivered the Registration
Rights Agreement.
VII. TERMINATION AND ABANDONMENT
7.1. Termination. Notwithstanding anything to the contrary in this
Agreement, this Agreement may be terminated at any time prior to the Closing by
mutual written consent of the Company, on the one hand, and the Investor on the
other.
VIII. MISCELLANEOUS
8.1. Nonsurvival of Representations, Warranties and Covenants. None of the
representations, warranties or covenants in this Agreement will survive the
Closing.
8.2. Amendment and Modification. Subject to applicable Law, this Agreement
may be amended, modified, or supplemented only by the written agreement of the
parties hereto before the Closing.
8.3. Waiver of Compliance. Except as otherwise provided in this Agreement,
the failure by any Person to comply with any obligation, covenant, agreement or
condition may be waived by the Person entitled to the benefit thereof only by a
written instrument signed by the Person granting such waiver, but such waiver or
failure to insist upon strict compliance with such obligation, covenant,
agreement or condition will not operate as a waiver of, or estoppel with respect
to, any subsequent or other failure. The failure of any Person to enforce at any
time any of the provisions of this Agreement will in no way be construed to be a
waiver of any such provision, nor in any way to affect the validity of this
Agreement or any part of this Agreement or the right of any Person thereafter to
enforce each and every such provision. No waiver of any breach of any provisions
of this Agreement will be held to be a waiver of any other or subsequent breach.
8.4. Notices. All notices required or permitted pursuant to this Agreement
will be in writing and will be deemed to be properly given when actually
received by the Person entitled to receive the notice at the address stated
below, or at such other address as a party may provide by notice to the other:
If to the Investor:
c/o 000 Xxxxxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxxxx X. Xxxxxxx
Facsimile: (000) 000 0000
-12-
With a copy to:
Xxxx, Weiss, Rifkind, Xxxxxxx & Xxxxxxxx LLP
0000 Xxxxxx xx xxx Xxxxxxxx
Xxx Xxxx, Xxx Xxxx 00000 6064
Attention: Xxxxx X. Xxxxxxxxx
Xxxxxx X. Xxxxxxx
Facsimile: (000) 000 0000
and:
Xxx Xxxxxxxxxx Xxxxxxx Xxxxx
Xxxxxxxxxx, Xxxxxxx 00000
Attention: General Counsel
Facsimile: (000) 000 0000
If to the Company:
Salton, Inc.
0000 X. Xxxxx Xxxxx
Xxxx Xxxxxx, Xxxxxxxx 00000
Attention:
Facsimile: (000) 000 0000
With a copy to:
Xxxxxxxxxxxx Xxxx & Xxxxxxxxx LLP
7800 Sears Tower, 000 Xxxxx Xxxxxx Xxxxx
Xxxxxxx, XX 00000 6404
Attention: Xxxx Xxxxxxxxxx
Facsimile: 312.876.7934
8.5. Third Party Beneficiaries. Nothing in this Agreement, expressed or
implied, is intended to confer on any Person other than the parties hereto or
their respective successors and assigns any rights, remedies, obligations or
liabilities under or by reason of this Agreement.
8.6. Successors and Assigns. This Agreement will be binding upon and will
inure to the benefit of the signatories hereto and their respective successors
and permitted assigns. Neither the Company nor the Investor may assign this
Agreement or any of their rights or liabilities thereunder without the prior
written consent of the other parties hereto, and any attempt to make any such
assignment without such consent will be null and void. Any such assignment will
not relieve the party making the assignment from any liability under such
agreements.
8.7. Severability. The illegality or partial illegality of any of this
Agreement, or any provision hereof, will not affect the validity of the
remainder of this Agreement, or any
-13-
provision hereof, and the illegality or partial illegality of this Agreement
will not affect the validity of this Agreement in any jurisdiction in which such
determination of illegality or partial illegality has not been made, except in
either case to the extent such illegality or partial illegality causes this
Agreement to no longer contain all of the material provisions reasonably
expected by the parties to be contained herein.
8.8. Governing Law. This Agreement will be governed by and construed in
accordance with the internal Laws of the State of Delaware applicable to
Contracts made and wholly performed within such state, without regard to any
applicable conflict of laws principles.
8.9. Submission to Jurisdiction; Waivers. The Investor and the Company
irrevocably agree that any Action with respect to this Agreement, the
Transactions, any provision hereof, the breach, performance, validity or
invalidity hereof or for recognition and enforcement of any judgment in respect
hereof brought by another party hereto or its successors or permitted assigns
shall be brought and determined in the Court of Chancery or other courts of the
State of Delaware located in the State of Delaware, and the Investor and the
Company hereby irrevocably submit and consent with regard to any such Action or
proceeding for itself and in respect to its property, generally and
unconditionally, to the exclusive jurisdiction of the aforesaid courts. The
Investor and the Company hereby irrevocably waive, and agree not to assert, by
way of motion, as a defense, counterclaim or otherwise, in any Action with
respect to this Agreement, the Transactions, any provision hereof or the breach,
performance, enforcement, validity or invalidity hereof, (a) any claim that it
is not personally subject to the jurisdiction of the above named courts for any
reason, (b) that it or its property is exempt or immune from jurisdiction of any
such court or from any legal process commenced in such courts (whether through
service of notice, attachment prior to judgment, attachment in aid of execution
of judgment, execution of judgment or otherwise), and (c) to the fullest extent
permitted by applicable Laws, that (i) Action in any such court is brought in an
inconvenient forum, (ii) the venue of such Action is improper and (iii) this
Agreement, or the subject matter hereof, may not be enforced in or by such
courts. Each party hereto hereby agrees that, to the fullest extent permitted by
Law, service of any process, summons, notice or document by U.S. registered mail
to the respective addresses set forth in Section 8.4 shall be effective service
of process for any suit or proceeding in connection with this Agreement or the
transactions contemplated hereby.
8.10. Specific Performance. The parties hereby acknowledge and agree that
the failure of any party to perform its agreements and covenants hereunder,
including its failure to take all actions as are necessary on its part to the
consummation of the Transactions, will cause irreparable injury to the other
parties for which damages, even if available, will not be an adequate remedy.
Accordingly, each party hereby consents to the issuance of injunctive relief by
any court of competent jurisdiction to compel performance of such party's
obligations and to the granting by any court of the remedy of specific
performance of its obligations hereunder.
8.11. Counterparts. This Agreement may be executed in two or more
counterparts, all of which will be considered one and the same agreement and
will become effective when counterparts have been signed by each of the parties
and delivered to the other parties, it being understood that each party need not
sign the same counterpart.
-14-
8.12. Entire Agreement. This Agreement (including the documents and the
instruments referred to in this Agreement), the Registration Rights Agreement
and the Confidentiality Agreement constitute the entire agreement and supersedes
all prior agreements and understandings, both written and oral, among the
parties with respect to the subject matter of this Agreement.
8.13. Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE
FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY
JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER
OR IN CONNECTION WITH THIS AGREEMENT. EACH OF THE PARTIES HERETO (A) CERTIFIES
THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT
AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT, AS
APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN
THIS SECTION 8.13.
[SIGNATURES ON FOLLOWING PAGE]
-15-
IN WITNESS WHEREOF, each of the signatories hereto has caused this
Agreement to be signed by their respective duly authorized officers as of the
date first above written.
SALTON, INC.
By:
-------------------------------------
Name:
-----------------------------------
Title:
----------------------------------
HARBINGER CAPITAL PARTNERS MASTER
FUND I, LTD.
By: Harbinger Capital Partners Offshore
Manager, L.L.C., its investment manager
By:
-------------------------------------
Name: Xxxxxx X. Xxxxxxx
Title: Senior Managing Director
Exhibit A
FORM OF REGISTRATION RIGHTS AGREEMENT
(See attached)